If you have Medicare Part D, check the Medicare GLP-1 Bridge before you pay cash. Since July 1, 2026 it has offered certain brand-name GLP-1s for weight reduction at a $50 monthly copay to people who qualify. Most cash-pay telehealth programs are built around self-pay. That is a different path, and for many Medicare patients it costs far more.
For years, the short answer for Medicare patients was that Medicare does not pay for weight-loss drugs. That is still true of Part D itself. But 2026 brought a federal demonstration that changes the math for many people. This post explains what changed, where cash-pay telehealth fits, and when a different route makes more sense. Everything here was checked against CMS, KFF and manufacturer pages on October 29, 2026. Medicare rules change, so confirm the details with 1-800-MEDICARE or your plan.
The baseline: Part D and weight-loss drugs
By law, Medicare Part D cannot cover drugs used specifically for weight loss. According to KFF, Part D can cover GLP-1s when they are prescribed for other FDA-approved, medically accepted uses, such as type 2 diabetes, cardiovascular risk reduction or sleep apnea. If your clinician prescribes one of these drugs for one of those reasons, it goes through your regular Part D plan, with its own formulary, prior authorization rules and cost-sharing.
What the Medicare GLP-1 Bridge is
The Medicare GLP-1 Bridge is a CMS demonstration that runs July 1, 2026 through December 31, 2027, according to CMS's program page (last modified July 13, 2026). KFF reports it was first planned to end December 31, 2026, and was extended after CMS paused a separate Part D model called BALANCE.
$50 per fill
A flat copay that, per CMS, does not count toward your Part D deductible or out-of-pocket total. Extra Help does not apply to it.
Brand only
Wegovy (injection and tablet), Zepbound KwikPen and Foundayo tablets, per CMS's prescriber guide. Zepbound single-dose pens and vials are not included.
Prior authorization
The prescriber attests that you meet the criteria. Requests go to a central processor, not your Part D plan.
Who qualifies
CMS's prescriber guide (June 2026) lists the criteria. You must be 18 or older, have Part D coverage, and be prescribed the drug to reduce excess body weight and keep it off. You are not eligible through the Bridge if you already received a GLP-1 through your Part D plan, or have type 2 diabetes, moderate-to-severe sleep apnea, or MASH; those cases stay with your plan. At the time you started the drug, you also needed one of these:
- A BMI of at least 35; or
- A BMI of at least 30 plus heart failure with preserved ejection fraction, uncontrolled high blood pressure despite two medications, or chronic kidney disease stage 3a or higher; or
- A BMI of at least 27 plus prediabetes, a prior heart attack, a prior stroke, or symptomatic peripheral artery disease.
How it works in practice
- Your prescriber writes the prescriptionCMS asks prescribers to mark it for the Bridge and include an obesity diagnosis code.
- The pharmacy starts prior authorizationThe pharmacy sends the request to the prescriber, usually within 24 to 72 hours, per CMS.
- The prescriber attestsDecisions come back within 72 hours. Later fills generally do not need a new authorization unless you switch drugs.
- You pay $50 at the pharmacyOnly 28- or 30-day fills are covered.
One detail matters a lot for telehealth: CMS says the prescriber does not need to be enrolled in Medicare to prescribe and submit the Bridge prior authorization. They only need to not be on Medicare's Preclusion List. CMS's guide does not address telehealth specifically, so ask any telehealth service directly whether its clinicians will complete Bridge paperwork. Our post on who does the prior-authorization paperwork in telehealth covers how that hand-off usually works.
What cash-pay telehealth can and can't do
Most direct-to-consumer GLP-1 programs are built for self-pay. Several of the partner sites we checked say so directly. GobyMeds says it does not bill insurance. HealthRX says no insurance is required. Gala GLP-1 says insurance is not required. None of the compounded-medication pages we opened mentioned Medicare.
| Can do | Generally can't do |
|---|---|
| Offer a clinician visit for a weight-management evaluation | Bill Medicare for its own membership or visit fees (ask each provider) |
| Prescribe brand medication you buy at a manufacturer self-pay price | Run compounded GLP-1s through the Bridge, which covers only listed brand products |
| Sell compounded semaglutide or tirzepatide for cash | Make compounded drugs FDA-approved or Medicare-covered |
| Possibly send a brand prescription to your pharmacy for the Bridge, if its clinicians do the paperwork | Guarantee you meet Bridge eligibility criteria |
A note on manufacturer savings: Lilly's terms say its commercial Zepbound savings card excludes people in government programs, including Medicare. Its self-pay KwikPen card is cash-only, and you cannot submit those costs to any insurer. LillyDirect's Zepbound page points eligible Part D patients to the Bridge.
Compounded semaglutide and tirzepatide are not FDA-approved, and the Bridge lists only specific brand products. None of the CMS or KFF pages we checked describe any Medicare coverage for compounded GLP-1s for weight loss. If you choose compounded medication, expect to pay the full cost yourself.
The hybrid: telehealth that works with Medicare
Some telehealth services now offer a Medicare-specific route. Sesame Care has a Medicare weight-loss visit page (checked October 29, 2026). It says a provider confirms your Medicare coverage and submits the prior authorization. The page lists Zepbound KwikPen, Wegovy pen, Wegovy pill and Foundayo at a $50 monthly copay if you qualify, with a separately billed membership starting at $59 per month. Prescriptions can go to the pharmacy of your choice.
That page does not say whether Sesame bills Medicare for the membership itself, so assume the membership is out of pocket unless the provider confirms otherwise.
Partners to check, listed alphabetically and not ranked. Prices change; confirm the current quote and terms on each provider's site. You can also browse the full provider directory.
Sesame Care
Lists a Medicare weight-loss visit path: the provider confirms coverage and submits prior authorization. Its membership is billed separately; ask whether Medicare covers any of it.
Paid partner linkWhen to use a Medicare-participating clinician instead
A cash-pay program may still make sense if you do not qualify for the Bridge and choose to self-pay. But a clinician who works within Medicare is often the better first stop when:
- You have type 2 diabetes, sleep apnea, MASH or heart disease. Your drug may be covered through your Part D plan for that condition, not through the Bridge.
- You want visits, labs and follow-up billed to Medicare rather than paid as a membership.
- You take several medications and want one clinician who sees the whole list.
- You think you meet a Bridge BMI-plus-condition criterion and need records documenting it.
Many people do both: a primary care clinician handles prescribing and prior authorization, and a telehealth service fills a specific gap. If you leave a service later, take your records with you; see how to leave a GLP-1 telehealth service without losing your records.
Open enrollment: October 15 to December 7, 2026
CMS says Medicare Open Enrollment runs from October 15 to December 7 each year, so this year's window covers 2027 plans. During it you can change your Medicare Advantage or Part D plan. Because the Bridge requires Part D coverage and sits outside your plan's benefit, the main questions this season are:
- Will your 2027 plan include Part D drug coverage, so you stay eligible for the Bridge?
- If you take a GLP-1 for diabetes, heart or sleep apnea, is it on your 2027 plan's formulary, and at what tier?
- Are your preferred pharmacies in network for 2027?
Compare plans at Medicare.gov or by calling 1-800-MEDICARE (1-800-633-4227). CMS notes that plans can change cost, coverage and pharmacy networks every year, so review your plan's Annual Notice of Change even if you plan to stay put.
Ask any clinician one question: "Do I meet any of the Medicare GLP-1 Bridge criteria, and will you submit the prior authorization?" If the answer is yes, compare the $50 copay against any cash price before enrolling anywhere.
Frequently asked questions
Does Medicare cover GLP-1 drugs for weight loss in 2026?
Part D itself still can't cover drugs used only for weight loss. But the Medicare GLP-1 Bridge, running July 1, 2026 through December 31, 2027, offers Wegovy, Zepbound KwikPen and Foundayo for weight reduction at a $50 monthly copay to Part D enrollees who meet its criteria.
Can a telehealth doctor prescribe through the Medicare GLP-1 Bridge?
CMS says the prescriber does not need to be enrolled in Medicare, as long as they are not on the Preclusion List. CMS's guide does not address telehealth directly, so ask the service whether its clinicians will complete Bridge prior authorization.
Does Medicare cover compounded semaglutide or tirzepatide?
The Bridge covers only specific brand products, and none of the CMS or KFF sources we checked describe Medicare coverage of compounded GLP-1s for weight loss. Compounded versions are not FDA-approved and are typically paid out of pocket.
Can I use a manufacturer coupon if I have Medicare?
Lilly's commercial Zepbound savings card excludes people in government programs, including Medicare. Its self-pay KwikPen card is cash-only and can't be submitted to any insurer. Check each program's terms.
When is Medicare open enrollment for 2027?
October 15 to December 7, 2026, according to CMS. You can change Medicare Advantage or Part D plans during this window.
Do I qualify for the Bridge if I have type 2 diabetes?
No. People with type 2 diabetes, moderate-to-severe sleep apnea or MASH are excluded from the Bridge because their GLP-1 may be covered through their regular Part D plan for that condition.
Sources
We opened each source below while preparing this article (checked October 29, 2026). Listing a source does not mean it endorses this site.
- CMS: Medicare GLP-1 Bridge (last modified July 13, 2026) — dates, copay, central processor
- CMS: Medicare GLP-1 Bridge, information for prescribers (June 2026) — eligibility criteria, covered drugs, prescriber enrollment
- CMS: Medicare GLP-1 Bridge, information for beneficiaries — contacts, prior authorization
- KFF: What to know about the BALANCE Model and the Medicare GLP-1 Bridge (May 11, 2026) — statutory exclusion, Bridge extension
- WebMD: Medicare GLP-1 Bridge eligibility (reviewed Sept. 7, 2026) — eligibility summary
- CMS: Medicare Open Enrollment — October 15 to December 7
- Lilly: Zepbound self-pay terms and conditions — government-program exclusions
- LillyDirect: Zepbound — Bridge referral for Part D patients
- Sesame: Medicare weight-loss visit — Medicare path, membership pricing
- GobyMeds: Weight loss treatment page — does not bill insurance
- HealthRX: Semaglutide — no insurance required
- Gala GLP-1 — insurance not required
- FDA: Concerns with unapproved GLP-1 drugs used for weight loss — compounded drugs not FDA-approved